One in four people experience mild side effects from Covishi

One in four people experience mild side effects from Covishield vaccine: Lancet study


Updated:
Systemic effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea.
Share Article
AAA
Covishield vaccine vial at the COVID-19 vaccination centre in Coimbatore on Tuesday April 27, 2021.   | Photo Credit: PERIASAMY M
Systemic effects included headache, fatigue, chills and shiver, diarrhoea, fever, arthralgia, myalgia, and nausea.
One in four people experience mild, short lived systemic side effects after receiving the COVID-19 preventive by Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccine — known as Covishield in India — with headache, fatigue and tenderness the most common symptoms, according to a study published in the
Lancet Infectious Diseases journal.
The researchers from King's College London in the U.K. also found that most systemic side effects — meaning side effects excluding where the injection took place — peaked within the first 24 hours following vaccination and usually lasted 1-2 days.

Related Keywords

London , City Of , United Kingdom , India , Oxford Astrazeneca Chadox , Tim Spector , King College London , Pfizer , Astrazeneca , Professor At King College London , Lancet Infectious Diseases , College London , Professor Tim Spector , Corona Virus , Vaccine , Vaccine Side Effect , Pfizer Biontech , Oxford Astrazeneca , Covid 19 Vaccines , லண்டன் , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , இந்தியா , நேரம் ஸ்பெக்டர் , கிங் கல்லூரி லண்டன் , ஃபைசர் , ப்ரொஃபெஸர் இல் கிங் கல்லூரி லண்டன் , கல்லூரி லண்டன் , ப்ரொஃபெஸர் நேரம் ஸ்பெக்டர் , கொரோனா வைரஸ் , தடுப்பூசி , தடுப்பூசி பக்க விளைவு ,

© 2025 Vimarsana